7 Documents disponibles écrits par cet auteur
UK and international evidence suggests that the prevalence of drug use, relative to that in the general population, is high among young adults, 'clubbers' (those who frequently use the night-time economy and dance venues/nightclubs) and lesbian,[...]
The aim of this paper is to focus on the harmful interaction between psychoactive drug use and sexual activity. It is acknowledged that in some individuals co-occurrence of drug consumption and sexual activity causes no apparent harm, but this g[...]
Royal College of Psychiatrists ; O. BOWDEN-JONES ; C. FITCH ; C. HILTON ; J. LEWIS ; G. OFORI-ATTAH | 2014
RapportServices are under pressure due to the concerning number of users of club drugs - psychoactive substances used in nightclubs, bars and festivals - such as ketamine and mephedrone. It is estimated more than one million adults a year use club drug[...]
O. BOWDEN-JONES ; M. Z. IQBAL ; P. TYRER ; N. SEIVEWRIGHT ; S. COOPER ; A. JUDD ; T. WEAVER | 2004
PériodiqueFRANÇAIS : Etude transversale auprès de 216 patients usagers de drogues et 64 patients usagers d'alcool pris en charge dans des centres urbains au Royaume-Uni. La prévalence des troubles de la personnalité est de 37% chez les usagers de drogue[...]![Responding to medicinal and non-medicinal ketamine use [Editorial]](https://bdoc.ofdt.fr/thumbnail.php?type=1&id=88233&database=pmb_ofdt)
O. BOWDEN-JONES ; A. SAHAI ; P. DARGAN | 2025
Dans Addiction (Vol.120, n°8, August 2025) Article : PériodiqueKetamine is an established anaesthetic and novel treatment for depression. Concurrently, non-pharmaceutical use of ketamine has increased across the world, with harms including accidental injury, psychological dependence and urinary tract damage[...]
T. WEAVER ; N. METREBIAN ; J. HELLIER ; S. PILLING ; V. CHARLES ; N. LITTLE ; D. POOVENDRAN ; L. MITCHESON ; F. RYAN ; O. BOWDEN-JONES ; J. DUNN ; GLASPER A. ; E. FINCH ; J. STRANG | 2014
Dans Lancet (The) (Vol.384, n°9938, July 12, 2014) Article : PériodiqueBACKGROUND. Poor adherence to treatment diminishes its individual and public health benefit. Financial incentives, provided on the condition of treatment attendance, could address this problem. Injecting drug users are a high-risk group for hepa[...]
Historique
